I have been in contact with two people regarding the AUT00063 clinical trial: Mr. Large (CEO and sponsor of trial) and
another person "on the other side of the fence" ie. the clinical trial itself. It is important to understand that the clinical trial sponsor, and the ones who actually carry out the trial, are two different entities. The sponsor is not allowed to have direct patient contact. And the executive arm of the clinical trial is
double-blind (meaning they don't know what they are administering - be it placebos or the "real deal" - to the patients, even though they are doctors; consequently, the patients are just as "blind" as the doctors in a double blind trial). This is the "segregation aspect" of a clinical trial.
I doubt many people realize(d) the importance of the post I made a few entries above ie. possible enrollment of non-UK nationals in the trial. As a counter example, even if I had mother tongue German competency, I would not be allowed to participate in the AM101 clinical trial here in Germany (even though I live here and have official healthcare coverage). That's why I had to go through all the off-label "crap"...
The tinnitus clinical trial is UK based (for certain). There possibly is another clinical in the US (for hearing loss; not confirmed - at least not to me). The criteria for enrollment could well be different for those two (speculation on my part, of course).
The source "on the other side of the fence" has already told me he/she knows there will not be "enough seats" for everyone (no surprise there - this is a phase II trial ie. small numbers to demonstrate efficacy). But once enrollment is possible via the resource webpage, you should have a go at it.
You will have to wait and see, is the simple answer to that. But, I suspect that they will request something like the following:
1) Possible restrictions on how long you have had tinnitus ("possibly" - I don't know!) eg. enrollment may be restricted to candidates who have had tinnitus for up to 12 months (example only!!!).
2) No other on-going tinnitus treatments (eg. AM101 trial).
3) Medication free (or nearly so) - eg. no
Trobalt in your system please...!
Again, the above is pure speculation on my part. You will probably be asked to submit a blood sample and a urine test. And possibly your medical file (from somewhere).
The person I have been in contact with has told me - as I already know - that this is a clinical trial, and there are strict procedures for inclusion/exclusion criteria. A clinical trial is not about "the patient" - it is about all the many future patients who potentially can benefit from the medication. The clinical trial itself could not care less about you. They only want people who fit the profile. Anyone on the borderline is just a nuisance to them.
I doubt it will get fast-tracked (I can't see the specific reason why it should ie. there is no threat to humanity or likewise). The person I have been in contact with has already confirmed to me that there is much work to done. Again, no surprise there since this is just the very beginning of phase II trial.
Regarding Flupirtine, I will provide an update on Monday or Tuesday after seeing my GP.